Home/Filings/4/0001209191-11-062618
4//SEC Filing

McIntyre David 4

Accession 0001209191-11-062618

CIK 0001389072other

Filed

Dec 20, 7:00 PM ET

Accepted

Dec 21, 6:23 PM ET

Size

23.0 KB

Accession

0001209191-11-062618

Insider Transaction Report

Form 4
Period: 2011-12-19
Transactions
  • Sale

    Common Stock

    2011-12-20$68.80/sh424$29,1710 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2011-12-195,7140 total
    Exercise: $38.41Exp: 2016-10-28Common Stock (5,714 underlying)
  • Exercise/Conversion

    Common Stock

    2011-12-19$38.41/sh+5,714$219,4755,714 total
  • Sale

    Common Stock

    2011-12-19$68.93/sh1,600$110,2880 total
  • Sale

    Common Stock

    2011-12-20$68.09/sh2,701$183,911424 total
  • Exercise/Conversion

    Restricted Stock Unit

    2011-12-203,1259,375 total
    From: 2011-12-20Exp: 2011-12-20Common Stock (3,125 underlying)
  • Sale

    Common Stock

    2011-12-19$69.12/sh1,623$112,1820 total
  • Sale

    Common Stock

    2011-12-19$68.08/sh4,114$280,0811,600 total
  • Exercise/Conversion

    Common Stock

    2011-12-20+3,1253,125 total
Holdings
  • Restricted Stock Unit

    From: 2012-09-16Exp: 2012-09-16Common Stock (24,166 underlying)
    24,166
Footnotes (11)
  • [F1]These shares were sold pursuant to a pre-arranged trading plan in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
  • [F10]The option was exercisable in four equal installments on October 28, 2007, 2008, 2009 and 2010, respectively.
  • [F11]Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
  • [F2]The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $68.71 to $69.68. The reporting person has provided the issuer and will provide any security holder of the issuer or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F3]The purchase price of US$38.41 has been converted from AU$38.50 at the spot rate on the date of the transaction.
  • [F4]The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $67.59 to $68.58. The reporting person has provided the issuer and will provide any security holder of the issuer or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F5]The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $68.61 to $69.31. The reporting person has provided the issuer and will provide any security holder of the issuer or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F6]On December 20, 2010, the reporting person was granted restricted stock units to acquire 12,500 shares of HeartWare International common stock. The award vests in four equal annual installments commencing on December 20, 2011. On December 20, 2011, 3,125 shares of common stock were issued to the reporting person.
  • [F7]The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $67.59 to $68.53. The reporting person has provided the issuer and will provide any security holder of the issuer or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F8]The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $68.65 to $69.30. The reporting person has provided the issuer and will provide any security holder of the issuer or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F9]The exercise price of US$38.41 has been converted from AU$38.50 at the spot rate on the date of the transaction.

Issuer

HeartWare International, Inc.

CIK 0001389072

Entity typeother

Related Parties

1
  • filerCIK 0001404254

Filing Metadata

Form type
4
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 6:23 PM ET
Size
23.0 KB